Clinical Trial: NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07114874) titled 'NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia' on July 29.

Brief Summary: This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

Study Start Date: July 11

Study Type: INTERVENTIONAL

Condition: Schizophrenia

Intervention: DRUG: NBI-1117568

NBI-1117568 will be administered per schedule specified in the arm description.

Recruitment Status: RECRUITING

Sponsor: Neurocrine Biosciences

Published by HT Digital Content Services with permission from Health Daily Digest....